West Pharmaceutical Services, Inc. balance sheet
At the end of its fiscal year on Dec 31, 2025, West Pharmaceutical Services, Inc. reported total assets of $4.27B and shareholders' equity of $3.18B. That works out to liabilities equal to 26% of assets, a current ratio of 3.02 (current assets ÷ current liabilities), long-term debt of 0.06× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.72B | $1.86B | $1.98B | $2.34B | $2.79B | $3.31B | $3.62B | $3.83B | $3.64B | $4.27B |
| Current assets | $641.90M | $743.50M | $894.40M | $1.06B | $1.37B | $1.74B | $1.92B | $1.94B | $1.54B | $1.98B |
| Cash & equivalents | $203.00M | $235.90M | $337.40M | $439.10M | $615.50M | $762.60M | $894.30M | $853.90M | $484.60M | $791.30M |
| Total liabilities | $599.20M | $582.90M | $582.60M | $768.20M | $939.30M | $978.40M | $931.90M | $948.50M | $961.10M | $1.09B |
| Current liabilities | $241.00M | $279.50M | $283.70M | $341.60M | $503.40M | $594.10M | $519.00M | $671.80M | $550.40M | $654.90M |
| Long-term debt | $226.20M | $197.00M | $196.00M | $255.00M | $252.90M | $208.80M | $206.70M | $72.80M | $202.60M | $202.80M |
| Shareholders' equity | $1.12B | $1.28B | $1.40B | $1.57B | $1.85B | $2.34B | $2.68B | $2.88B | $2.68B | $3.18B |
| Reported in | 10-K 2019 | 10-K 2020 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 105770 (raw data). Most recent filing in this dataset: 10-Q filed Oct 29, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.